These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 35593700)

  • 1. Individualized discovery of rare cancer drivers in global network context.
    Petrov I; Alexeyenko A
    Elife; 2022 May; 11():. PubMed ID: 35593700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
    Merid SK; Goranskaya D; Alexeyenko A
    BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
    Zhang J; Zhang S; Wang Y; Zhang XS
    BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovering potential cancer driver genes by an integrated network-based approach.
    Shi K; Gao L; Wang B
    Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DriverRWH: discovering cancer driver genes by random walk on a gene mutation hypergraph.
    Wang C; Shi J; Cai J; Zhang Y; Zheng X; Zhang N
    BMC Bioinformatics; 2022 Jul; 23(1):277. PubMed ID: 35831792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
    Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
    Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
    Narayan S; Bader GD; Reimand J
    Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of constrained cancer driver genes based on mutation timing.
    Sakoparnig T; Fried P; Beerenwinkel N
    PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel network control model for identifying personalized driver genes in cancer.
    Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
    PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
    Zhang W; Wang SL
    Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.
    Wang L; Li F; Sheng J; Wong ST
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S6. PubMed ID: 26099165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo discovery of mutated driver pathways in cancer.
    Vandin F; Upfal E; Raphael BJ
    Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features.
    Lanzós A; Carlevaro-Fita J; Mularoni L; Reverter F; Palumbo E; Guigó R; Johnson R
    Sci Rep; 2017 Jan; 7():41544. PubMed ID: 28128360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
    Bokhari Y; Alhareeri A; Arodz T
    BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations.
    Ashford P; Pang CSM; Moya-García AA; Adeyelu T; Orengo CA
    Sci Rep; 2019 Jan; 9(1):263. PubMed ID: 30670742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KatzDriver: A network based method to cancer causal genes discovery in gene regulatory network.
    Akhavan-Safar M; Teimourpour B
    Biosystems; 2021 Mar; 201():104326. PubMed ID: 33309969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding oncogenicity of cancer driver genes and mutations in the cancer genomics era.
    Porta-Pardo E; Valencia A; Godzik A
    FEBS Lett; 2020 Dec; 594(24):4233-4246. PubMed ID: 32239503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
    Liu X; Wang J; Chen L
    Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ontology-based prediction of cancer driver genes.
    Althubaiti S; Karwath A; Dallol A; Noor A; Alkhayyat SS; Alwassia R; Mineta K; Gojobori T; Beggs AD; Schofield PN; Gkoutos GV; Hoehndorf R
    Sci Rep; 2019 Nov; 9(1):17405. PubMed ID: 31757986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying overlapping mutated driver pathways by constructing gene networks in cancer.
    Wu H; Gao L; Li F; Song F; Yang X; Kasabov N
    BMC Bioinformatics; 2015; 16 Suppl 5(Suppl 5):S3. PubMed ID: 25859819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.